✦ LIBER ✦

Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus

✍ Scribed by Singh, Sonal; Chang, Hsien-Yen; Richards, Thomas M.; Weiner, Jonathan P.; Clark, Jeanne M.; Segal, Jodi B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glucagon- Like Peptide-1-Based Therapies

✍ Prof. Baptist Gallwitz 📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 162 KB

Extra-pancreatic effects of incretin-bas

✍ van Genugten, R. E.; Möller-Goede, D. L.; van Raalte, D. H.; Diamant, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 572 KB

Risk of Acute Pancreatitis in Type 2 Dia

✍ Lai, Shih-Wei; Muo, Chih-Hsin; Liao, Kuan-Fu; Sung, Fung-Chang; Chen, Pei-Chun 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 168 KB

Incretin therapies and risk of hospital

✍ Giorda, Carlo B; Picariello, Roberta; Nada, Elisa; Tartaglino, Barbara; Marafett 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 229 KB

Effects of therapy in type 1 and type 2

✍ Kathleen M. Dungan; John B. Buse; Robert E. Ratner 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Incretin-based Therapies (Glucagon-like

✍ Amir Hanna; Vincent Woo; Jean-François Yale; Elaine M. Cooke 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 208 KB